The cancer-focused antibody developer has secured $58.5m in a US flotation that involved existing investors Celgene and Eli Lilly buying more than $7m of shares.

Big data software provider Cloudera has gone public, but the gap between its market cap and the valuation at which Intel invested three years ago may be an ill omen for backers of other unicorns.

The oncology drug developer has raised $92.5m in VC funding, $11.5m of which came from MedImmune Ventures, the CVC unit that now owns a 16.7% stake.

The Thomson Reuters-backed data analytics platform developer floated at the top of its range and its stock finished almost 11% up on its first day of trading.

Fintech developer Ayondo is set to list on the Singapore Exchange at a $158m valuation, giving ProSiebenSat.1 an exit.

Legend Capital has scored a significant exit as the graphite film producer, in which it held a share of almost 13%, floated in Shanghai.

The software integration specialist floated above its range on Friday in an offering that could be the first of some hefty returns for Salesforce Ventures' stable of unicorns in 2017.

The renewable chemicals technology developer, which counts Coca-Cola and Swire among its corporate shareholders, is now listed in Belgium and the Netherlands.

The visual media company has sold an additional 30 million shares to close an offering that provided exits to Yahoo, Tencent and Alibaba.

Tencent, Alibaba and Yahoo celebrate an exit as Snap prices its shares at $17 a piece to reach a valuation of approximately $24bn.